Marc Goodman
Stock Analyst at Leerink Partners
(4.89)
# 301
Out of 5,119 analysts
819
Total ratings
54.9%
Success rate
18.1%
Average return
Main Sectors:
Stocks Rated by Marc Goodman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EOLS Evolus | Reiterated: Buy | $20 | $6.81 | +193.90% | 44 | Nov 5, 2026 | |
| EPA: MEDCL MedinCell S.A. | Reiterated: Buy | €29.44 | €28.44 | +3.51% | 1 | Oct 12, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $52 | $24.44 | +112.77% | 1 | Jun 24, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | n/a | $26.54 | - | 11 | Jun 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $35 | $21.50 | +62.79% | 1 | May 27, 2026 | |
| ACIU AC Immune | Reiterated: Buy | n/a | $2.23 | - | 38 | Apr 7, 2026 | |
| ALKS Alkermes | Reiterated: Hold | n/a | $45.90 | - | 45 | Mar 31, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $42 | $36.95 | +13.68% | 1 | Mar 3, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $75 | $138.78 | -45.96% | 1 | Mar 2, 2026 | |
| NMRA Neumora Therapeutics | Initiated Coverage: Buy | $8 | $0.5033 | +1,489.51% | 1 | Jan 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $15 | $14.48 | +3.59% | 26 | Dec 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $6.93 | +332.90% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.85 | +75.44% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $154.19 | n/a | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $7.49 | n/a | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $30 | $21.23 | n/a | 46 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $20 | $29.50 | n/a | 34 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $132.37 | n/a | 52 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $248.35 | n/a | 58 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 | $234.76 | n/a | 54 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $39.17 | n/a | 31 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $42.01 | n/a | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $164.63 | n/a | 48 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.42 | n/a | 4 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $20.07 | n/a | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.6337 | n/a | 40 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $33.27 | n/a | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $3.50 | n/a | 11 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.90 | n/a | 33 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.015 | n/a | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $276.22 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $10.29 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $1.04 | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $1.36 | n/a | 12 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $78.91 | n/a | 10 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.95 | n/a | 2 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $46.96 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $174.76 | n/a | 1 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.63 | n/a | 1 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $337.52 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $547.09 | n/a | 2 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $473 | $904.35 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $72 → $57 | $62.14 | n/a | 17 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $54 | $19.91 | n/a | 8 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $29.39 | n/a | 15 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $146.73 | n/a | 16 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $291.31 | n/a | 14 | Oct 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $98 | $15.85 | n/a | 8 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $1,354.00 | n/a | 12 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $12 | $20.14 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $166.89 | n/a | 3 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $4.39 | n/a | 3 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.56 | n/a | 24 | Mar 21, 2016 |
Evolus
Nov 5, 2026
Reiterated: Buy
Price Target: $20
Current: $6.81
Upside: +193.90%
MedinCell S.A.
Oct 12, 2026
Reiterated: Buy
Price Target: €29.44
Current: €28.44
Upside: +3.51%
Rapport Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $24.44
Upside: +112.77%
Stoke Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.54
Upside: -
Seaport Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $21.50
Upside: +62.79%
AC Immune
Apr 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.23
Upside: -
Alkermes
Mar 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $45.90
Upside: -
SpyGlass Pharma
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $36.95
Upside: +13.68%
Veradermics
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $138.78
Upside: -45.96%
Neumora Therapeutics
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $0.5033
Upside: +1,489.51%
Dec 25, 2025
Reiterated: Buy
Price Target: $50 → $15
Current: $14.48
Upside: +3.59%
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $6.93
Upside: +332.90%
Nov 17, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.85
Upside: +75.44%
Oct 15, 2025
Reiterated: Buy
Price Target: $85
Current: $154.19
Upside: n/a
Oct 9, 2025
Reiterated: Buy
Price Target: $50
Current: $7.49
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: $32 → $30
Current: $21.23
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: $10 → $20
Current: $29.50
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $132.37
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $248.35
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: $215
Current: $234.76
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $39.17
Upside: n/a
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $34
Current: $42.01
Upside: n/a
Sep 23, 2025
Reiterated: Buy
Price Target: n/a
Current: $164.63
Upside: n/a
Sep 16, 2025
Reiterated: Buy
Price Target: $20
Current: $2.42
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $40
Current: $20.07
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $10
Current: $0.6337
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $20
Current: $33.27
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $36
Current: $3.50
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.90
Upside: n/a
Mar 26, 2025
Downgraded: Hold
Price Target: $1
Current: $0.015
Upside: n/a
Jan 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $276.22
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $4
Current: $10.29
Upside: n/a
Jan 24, 2023
Initiated Coverage: Buy
Price Target: $24
Current: $1.04
Upside: n/a
Jul 11, 2022
Reiterated: Hold
Price Target: $70
Current: $1.36
Upside: n/a
Jul 11, 2022
Reiterated: Hold
Price Target: $20
Current: $78.91
Upside: n/a
Jun 27, 2022
Reiterated: Hold
Price Target: n/a
Current: $5.95
Upside: n/a
May 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $46.96
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $25
Current: $174.76
Upside: n/a
May 4, 2021
Reiterated: Buy
Price Target: n/a
Current: $44.63
Upside: n/a
Apr 5, 2021
Reiterated: Buy
Price Target: $31
Current: $337.52
Upside: n/a
Mar 19, 2019
Downgraded: Hold
Price Target: n/a
Current: $547.09
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: $473
Current: $904.35
Upside: n/a
May 21, 2018
Downgraded: Hold
Price Target: $72 → $57
Current: $62.14
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $46 → $54
Current: $19.91
Upside: n/a
Jan 31, 2018
Reiterated: Buy
Price Target: $42
Current: $29.39
Upside: n/a
Oct 30, 2017
Reiterated: Buy
Price Target: $67
Current: $146.73
Upside: n/a
Oct 13, 2017
Reiterated: Hold
Price Target: $95
Current: $291.31
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $110 → $98
Current: $15.85
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $85
Current: $1,354.00
Upside: n/a
Nov 10, 2016
Reiterated: Sell
Price Target: $28 → $12
Current: $20.14
Upside: n/a
Nov 2, 2016
Reiterated: Buy
Price Target: $118
Current: $166.89
Upside: n/a
Jun 14, 2016
Reiterated: Sell
Price Target: $8
Current: $4.39
Upside: n/a
Mar 21, 2016
Rated: Buy
Price Target: n/a
Current: $11.56
Upside: n/a